Suchergebnisse - "Bhutani, Manisha"

PubPharm (126)

1

Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

enthalten in: Advances in therapy | 2024

von Einsele, H. | Moreau, P. | Bahlis, N. | +23

2

Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)

enthalten in: Life (Basel, Switzerland) | 2024

von Ehsan, H. | Robinson, M. | Voorhees, P. | +8

3

Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

enthalten in: Advances in therapy | 2024

von Einsele, H. | Moreau, P. | Bahlis, N. | +23

4

Addressing the disparities : the approach to the African American patient with multiple myeloma

enthalten in: Blood cancer journal | 2023

von Bhutani, M. | Blue, B. | Cole, C. | +5

5

Bone marrow Ki-67 index is of prognostic value in newly diagnosed multiple myeloma

enthalten in: European journal of haematology | 2023

von Atrash, S. | Robinson, M. | Taneja, A. | +13

6

Boosting CAR T cytopenias with backup autologous stem cells

enthalten in: Transplantation and cellular therapy | 2023

von Bhutani, M.

7

A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Bhutani, M. | Foureau, D. | Robinson, M. | +14

8

Disparities in multiple myeloma among African Americans

enthalten in: Journal of the National Medical Association | 2023

von Bhutani, M. | Lonial, S. | Mikhael, J.

9

Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study)

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Ehsan, H. | Britt, A. | Voorhees, P. | +8

10

Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Foureau, D. | Paul, B. | Guo, F. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]